PMS29 Abatacept or Infliximab for Patients with Rheumatoid Arthritis and Inadequate Response to Methotrexate- A Trial-Based and Real-Life Cost-Consequence Analysis

Nov 1, 2011, 00:00
10.1016/j.jval.2011.08.415
https://www.valueinhealthjournal.com/article/S1098-3015(11)01977-2/fulltext
Title : PMS29 Abatacept or Infliximab for Patients with Rheumatoid Arthritis and Inadequate Response to Methotrexate- A Trial-Based and Real-Life Cost-Consequence Analysis
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)01977-2&doi=10.1016/j.jval.2011.08.415
First page : A307
Section Title : Muscular-Skeletal Disorders
Open access? : No
Section Order : 390
Categories :
Tags :
Regions :
ViH Article Tags :